ASSESSMENT DAY TESTING FIBRINOLYTICS IN PATIENTS AT RISK OF VOD AFTER TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS: STUDY IN A PEDIATRIC POPULATION